Aidar R Gosmanov1, Jun L Lu, Keiichi Sumida, Praveen K Potukuchi, Connie M Rhee, Kamyar Kalantar-Zadeh, Miklos Z Molnar, Csaba P Kovesdy. 1. aDivision of Endocrinology, Diabetes, and Metabolism bDivision of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee cDivision of Nephrology and Hypertension, Department of Medicine, University of California, Irvine, CA dNephrology Section, Memphis Veterans Affairs Medical Center, Memphis, Tennessee, USA *Current affiliation: Endocrinology Section, Stratton VA Medical Center, Albany, New York, USA.
Abstract
OBJECTIVES: Hemoglobin A1c levels less than 7.0% and systolic blood pressure (SBP) less than 140 mmHg are each associated with lower risk of vascular complications in patients with diabetes mellitus. Associations between combined A1c level and SBP categories and risk of mortality and morbidity in diabetic patients are not well characterized. METHODS: We examined 891 670 US diabetic veterans with baseline estimated glomerular filtration rates more than 60 ml/min per 1.73 m (mean age 67 ± 11 years, 97% men, 17% African-Americans). The associations of mutually exclusive combined categories of A1c (<6.5, 6.5-6.9, 7.0-7.9, 8.0-8.9, 9.0-9.9, and ≥10%) and SBP (<100, 100-119, 120-139, 140-159, 160-179, and ≥180 mmHg) with the risk of all-cause mortality and incident chronic kidney disease (CKD), coronary heart disease, and stroke were examined in Cox models adjusted for baseline characteristics using patients with concomitant A1c 6.5-6.9% and SBP of 120-139 mmHg as the referent group. RESULTS: A total of 221 529 (25%) patients died, and 178 588 (20%), 43 373 (5%) and 36 935 (4%) developed CKD, coronary heart disease and stroke, respectively, during a median follow-up of 7.4 years. SBP displayed a J-shaped association with each outcome except CKD risk that was linearly associated with SBP across all A1c categories. A1c above 7.0% was associated with monotonically worse outcomes for all end points in all SBP categories. Patients with the combined highest A1c and SBP levels experienced the worst outcomes. CONCLUSION: SBP greater than 120-139 mmHg and A1c greater than 7.0% are associated with higher mortality and vascular complications in diabetic patients, independent of each other. Combined efforts to improve both glycemic and blood pressure control may synergistically improve outcomes in patients with normal kidney function.
OBJECTIVES: Hemoglobin A1c levels less than 7.0% and systolic blood pressure (SBP) less than 140 mmHg are each associated with lower risk of vascular complications in patients with diabetes mellitus. Associations between combined A1c level and SBP categories and risk of mortality and morbidity in diabeticpatients are not well characterized. METHODS: We examined 891 670 US diabetic veterans with baseline estimated glomerular filtration rates more than 60 ml/min per 1.73 m (mean age 67 ± 11 years, 97% men, 17% African-Americans). The associations of mutually exclusive combined categories of A1c (<6.5, 6.5-6.9, 7.0-7.9, 8.0-8.9, 9.0-9.9, and ≥10%) and SBP (<100, 100-119, 120-139, 140-159, 160-179, and ≥180 mmHg) with the risk of all-cause mortality and incident chronic kidney disease (CKD), coronary heart disease, and stroke were examined in Cox models adjusted for baseline characteristics using patients with concomitant A1c 6.5-6.9% and SBP of 120-139 mmHg as the referent group. RESULTS: A total of 221 529 (25%) patients died, and 178 588 (20%), 43 373 (5%) and 36 935 (4%) developed CKD, coronary heart disease and stroke, respectively, during a median follow-up of 7.4 years. SBP displayed a J-shaped association with each outcome except CKD risk that was linearly associated with SBP across all A1c categories. A1c above 7.0% was associated with monotonically worse outcomes for all end points in all SBP categories. Patients with the combined highest A1c and SBP levels experienced the worst outcomes. CONCLUSION: SBP greater than 120-139 mmHg and A1c greater than 7.0% are associated with higher mortality and vascular complications in diabeticpatients, independent of each other. Combined efforts to improve both glycemic and blood pressure control may synergistically improve outcomes in patients with normal kidney function.
Authors: Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh Journal: Ann Intern Med Date: 2013-08-20 Impact factor: 25.391
Authors: William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi Journal: N Engl J Med Date: 2010-03-14 Impact factor: 91.245
Authors: Christina M Parrinello; Ina Rastegar; Job G Godino; Michael D Miedema; Kunihiro Matsushita; Elizabeth Selvin Journal: Diabetes Care Date: 2015-04-07 Impact factor: 19.112
Authors: Sarah Stark Casagrande; Judith E Fradkin; Sharon H Saydah; Keith F Rust; Catherine C Cowie Journal: Diabetes Care Date: 2013-02-15 Impact factor: 19.112
Authors: Karen L Margolis; Patrick J O'Connor; Timothy M Morgan; John B Buse; Robert M Cohen; William C Cushman; Jeffrey A Cutler; Gregory W Evans; Hertzel C Gerstein; Richard H Grimm; Edward W Lipkin; K M Venkat Narayan; Matthew C Riddle; Ajay Sood; David C Goff Journal: Diabetes Care Date: 2014-03-04 Impact factor: 19.112
Authors: Elvira O Gosmanova; Margit K Mikkelsen; Miklos Z Molnar; Jun L Lu; Lenar T Yessayan; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: J Am Coll Cardiol Date: 2016-09-27 Impact factor: 24.094
Authors: Tai-Hing Lam; Karen Siu-Ling Lam; Hung-Fat Tse; Yap-Hang Chan; C Mary Schooling; Jie V Zhao; Shiu-Lun Au Yeung; Jo Jo Hai; G Neil Thomas; Kar-Keung Cheng; Chao-Qiang Jiang; Yuen-Kwun Wong; Ka-Wing Au; Clara S Tang; Chloe Y Y Cheung; Aimin Xu; Pak-Chung Sham Journal: Genes Nutr Date: 2022-01-29 Impact factor: 5.523
Authors: John Peter Mitsios; Elif Ilhan Ekinci; Gregory Peter Mitsios; Leonid Churilov; Vincent Thijs Journal: J Am Heart Assoc Date: 2018-05-17 Impact factor: 5.501